Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on R L prolinol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100584827C discloses efficient synthesis of chiral ligands from L-prolinol or ephedrine. High yield, room temperature reaction, and superior enantioselectivity for pharmaceutical intermediates.
Patent CN103450073A details a novel rigid chiral catalyst synthesis offering superior stereoselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Patent CN103450074A discloses a high-selectivity synthesis of R-L-prolinol derivatives. This novel route offers significant cost reduction in chiral catalyst manufacturing.
Patent CN109265385B discloses a low-cost, high-yield synthesis of chiral diphenyl prolinol using sulfuric acid catalysis, offering significant supply chain advantages.
Novel route for C2-symmetric diamines using tert-butylsulfinamide. High yield, scalable process for pharma intermediates.
Patent CN109265385B details a novel, scalable synthesis for chiral diphenyl prolinol, offering high optical purity and simplified process for cost reduction in pharmaceutical manufacturing.
Solve high-cost chiral catalyst production with 99.5% ee, 80% yield, and no toxic reagents. Scale to 100MT/yr with NINGBO INNO PHARMCHEM.